Top news of the week: 06.01.2022.
Career And Jobs
Biggest Biopharma Successes and Flops of 2021
From the continuing fight against COVID-19 to new companies emerging in exciting therapeutic areas to the people who mattered most, here’s a look at just some of the biggest successes, ...
Paracrine to Present at Biotech Showcase™ 2022
Update on Advancing Disease Modifying Cell Therapy into Late-Stage Clinical TrialsSAN DIEGO--(BUSINESS WIRE)--Paracrine, Inc. announced today that it is presenting virtually at the Biotech ...
2021 drug approvals: In a year dominated by COVID, biopharma managed to deliver 55 new drugs
Each year, many scientists and other experts working in the biopharma industry see years of their work culminate in FDA approvals. With the COVID-19 crisis stretching into its third year, ...
The Future of Biotech in an Artificially Intelligent World
Biotech will benefit from AI capabilities that include protein structure prediction, pattern recognition, and support for iterative processes.
Anebulo Pharmaceuticals Names Biotechnology Industry Executive Simon Allen as CEO and Director
AUSTIN, Texas--(BUSINESS WIRE)--Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute ...
Blueprint's longtime CEO prepares to step down as biotech revels in new Ayvakit launch, pipeline expansion
After a busy 2021 brought Blueprint Medicines its fourth FDA approval, the company is kicking off the new year with plans to shake up its C-suite. Jeff Albers, Blueprint’s CEO for the past ...
Racial disparities continue to plague biopharma workforce, report finds—but boards do have more women
Originally published by Fierce Pharma on January 4, 2022 Massachusetts is arguably the largest life sciences hub in the world, but, much like the industry as a whole, its biopharma ...
Zymeworks Names Biotechnology Industry Leader Kenneth Galbraith as Chair and CEO to Succeed Dr. Ali Tehrani
Co-founder Dr. Ali Tehrani to remain as an advisor to the Company to assist in the transition expected to occur on or before February 1, 2022Chief Financial Officer (CFO) Neil Klompas also ...